NS

Niru Sunil Singhal

Director Director DIN 05130306
DIN 05130306 First appointment Dec 2011 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Niru Sunil Singhal

Data last updated:

Niru Sunil Singhal was a Director at Early Cure Pharmacy Private Limited (2011–2017) and Director at Kuber Rising Developers Private Limited (from 2011). The companies operate in Pharma.

DIN 05130306
Primary Designation Director
Industry Pharma
First Appointment 19 Dec 2011
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Early Cure Pharmacy Private Limited U52100DL2011PTC229074
Director21 Dec 20112011₹1.19 Cr (FY 2024)Active
Director19 Dec 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kuber Rising Developers Private Limited
Early Cure Pharmacy Private Limited
Premium access

Shareholding and investment profile for Niru Sunil Singhal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Niru Sunil Singhal

Niru Sunil Singhal was first appointed on 19 Dec 2011 as Director at Kuber Rising Developers Private Limited.

Niru Sunil Singhal held 2 earlier board appointments: Early Cure Pharmacy Private Limited (Director, 21 Dec 2011 to 30 Jan 2017); Kuber Rising Developers Private Limited (Director, from 19 Dec 2011).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available